Structure

Physi-Chem Properties

Molecular Weight:  610.31
Volume:  629.154
LogP:  5.205
LogD:  3.274
LogS:  -4.405
# Rotatable Bonds:  12
TPSA:  150.59
# H-Bond Aceptor:  9
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.177
Synthetic Accessibility Score:  5.084
Fsp3:  0.629
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.046
MDCK Permeability:  1.752927346387878e-05
Pgp-inhibitor:  0.995
Pgp-substrate:  0.784
Human Intestinal Absorption (HIA):  0.637
20% Bioavailability (F20%):  0.219
30% Bioavailability (F30%):  0.962

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.319
Plasma Protein Binding (PPB):  92.35779571533203%
Volume Distribution (VD):  1.787
Pgp-substrate:  4.299668788909912%

ADMET: Metabolism

CYP1A2-inhibitor:  0.049
CYP1A2-substrate:  0.088
CYP2C19-inhibitor:  0.277
CYP2C19-substrate:  0.155
CYP2C9-inhibitor:  0.891
CYP2C9-substrate:  0.076
CYP2D6-inhibitor:  0.097
CYP2D6-substrate:  0.056
CYP3A4-inhibitor:  0.775
CYP3A4-substrate:  0.169

ADMET: Excretion

Clearance (CL):  4.982
Half-life (T1/2):  0.112

ADMET: Toxicity

hERG Blockers:  0.625
Human Hepatotoxicity (H-HT):  0.902
Drug-inuced Liver Injury (DILI):  0.893
AMES Toxicity:  0.011
Rat Oral Acute Toxicity:  0.863
Maximum Recommended Daily Dose:  0.956
Skin Sensitization:  0.531
Carcinogencity:  0.088
Eye Corrosion:  0.003
Eye Irritation:  0.012
Respiratory Toxicity:  0.982

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC11410

Natural Product ID:  NPC11410
Common Name*:   QXFOVBNLMKQJFC-NNGASTTLSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  QXFOVBNLMKQJFC-NNGASTTLSA-N
Standard InCHI:  InChI=1S/C35H46O9/c1-6-7-8-9-13-16-26(37)44-35-27(32(35,4)5)24-18-23(19-36)29(39)34(42)25(17-20(2)28(34)38)33(24,41)21(3)30(35)43-31(40)22-14-11-10-12-15-22/h10-12,14-15,17-18,21,24-25,27,29-30,36,39,41-42H,6-9,13,16,19H2,1-5H3/t21-,24+,25+,27-,29-,30-,33-,34-,35-/m1/s1
SMILES:  CCCCCCCC(=O)O[C@]12[C@H]([C@@H]3C=C(CO)[C@H]([C@]4([C@@H](C=C(C)C4=O)[C@]3([C@H](C)[C@H]1OC(=O)c1ccccc1)O)O)O)C2(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2375488
PubChem CID:   71712659
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0002875] Tigliane and ingenane diterpenoids
            • [CHEMONTID:0002906] Phorbol esters

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. root n.a. PMID[15997133]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. root n.a. PMID[16141313]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. callus n.a. PMID[22368856]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. n.a. n.a. PMID[23611151]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota roots n.a. n.a. PMID[24931277]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. n.a. n.a. PMID[26562066]
NPO40396 Wikstroemia scytophylla Species Thymelaeaceae Eukaryota n.a. n.a. n.a. PMID[33172265]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. root n.a. Database[Article]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO7067 Stellera chamaejasme Species Thymelaeaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT25 Cell Line MT4 Homo sapiens IC50 = 17200.0 nM PMID[521741]
NPT25 Cell Line MT4 Homo sapiens CC50 > 164.0 nM PMID[521742]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 EC90 = 0.0038 uM PMID[521741]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 IC50 = 12.8 nM PMID[521742]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC11410 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9793 High Similarity NPC469647
0.9793 High Similarity NPC469648
0.9793 High Similarity NPC138641
0.9793 High Similarity NPC22571
0.9793 High Similarity NPC283875
0.9658 High Similarity NPC145649
0.9658 High Similarity NPC233581
0.9589 High Similarity NPC472398
0.9527 High Similarity NPC251139
0.9517 High Similarity NPC132652
0.9172 High Similarity NPC140021
0.9172 High Similarity NPC183540
0.9067 High Similarity NPC471103
0.9067 High Similarity NPC51602
0.9032 High Similarity NPC43304
0.9032 High Similarity NPC477190
0.9032 High Similarity NPC477188
0.9013 High Similarity NPC473670
0.9013 High Similarity NPC21410
0.9 High Similarity NPC7095
0.8986 High Similarity NPC127857
0.8954 High Similarity NPC106895
0.8947 High Similarity NPC11588
0.8947 High Similarity NPC229545
0.8947 High Similarity NPC134685
0.8947 High Similarity NPC248265
0.894 High Similarity NPC470153
0.8933 High Similarity NPC81698
0.8933 High Similarity NPC60509
0.8933 High Similarity NPC250046
0.8919 High Similarity NPC34943
0.8889 High Similarity NPC26033
0.8889 High Similarity NPC259144
0.8889 High Similarity NPC282239
0.8889 High Similarity NPC114357
0.8889 High Similarity NPC228204
0.8889 High Similarity NPC155329
0.8874 High Similarity NPC165260
0.8874 High Similarity NPC161239
0.8874 High Similarity NPC112216
0.8874 High Similarity NPC198455
0.8861 High Similarity NPC61891
0.8859 High Similarity NPC134131
0.8859 High Similarity NPC25043
0.8854 High Similarity NPC66193
0.8851 High Similarity NPC95449
0.8839 High Similarity NPC49297
0.8824 High Similarity NPC472030
0.8824 High Similarity NPC472005
0.8824 High Similarity NPC265395
0.8824 High Similarity NPC242262
0.8824 High Similarity NPC256142
0.8824 High Similarity NPC249471
0.8824 High Similarity NPC219419
0.8824 High Similarity NPC1173
0.8824 High Similarity NPC304876
0.8824 High Similarity NPC158333
0.8824 High Similarity NPC237549
0.8824 High Similarity NPC472022
0.8824 High Similarity NPC473414
0.8824 High Similarity NPC257213
0.8816 High Similarity NPC197037
0.88 High Similarity NPC20255
0.88 High Similarity NPC312393
0.88 High Similarity NPC240115
0.8784 High Similarity NPC192658
0.8774 High Similarity NPC472393
0.8774 High Similarity NPC181924
0.8766 High Similarity NPC472549
0.8766 High Similarity NPC132599
0.8766 High Similarity NPC112523
0.8766 High Similarity NPC473632
0.8766 High Similarity NPC473611
0.8766 High Similarity NPC469730
0.8766 High Similarity NPC114410
0.875 High Similarity NPC470245
0.875 High Similarity NPC473214
0.875 High Similarity NPC125033
0.875 High Similarity NPC91730
0.8742 High Similarity NPC217918
0.8734 High Similarity NPC322420
0.8733 High Similarity NPC311825
0.8733 High Similarity NPC471107
0.8733 High Similarity NPC92867
0.8733 High Similarity NPC471100
0.8733 High Similarity NPC125882
0.8725 High Similarity NPC477894
0.8718 High Similarity NPC471102
0.8716 High Similarity NPC97947
0.8716 High Similarity NPC291599
0.8716 High Similarity NPC87448
0.8716 High Similarity NPC118080
0.8716 High Similarity NPC16912
0.8716 High Similarity NPC27377
0.8716 High Similarity NPC41481
0.8716 High Similarity NPC472576
0.871 High Similarity NPC70344
0.871 High Similarity NPC217091
0.8701 High Similarity NPC77719
0.8693 High Similarity NPC306799
0.8693 High Similarity NPC101043
0.8684 High Similarity NPC473215
0.8684 High Similarity NPC476975
0.8679 High Similarity NPC471134
0.8675 High Similarity NPC473602
0.8671 High Similarity NPC275477
0.8658 High Similarity NPC182869
0.8658 High Similarity NPC34012
0.8658 High Similarity NPC472546
0.8654 High Similarity NPC469771
0.8649 High Similarity NPC275592
0.8649 High Similarity NPC97667
0.8649 High Similarity NPC162613
0.8649 High Similarity NPC171207
0.8649 High Similarity NPC100913
0.8649 High Similarity NPC90614
0.8649 High Similarity NPC472547
0.8649 High Similarity NPC87934
0.8636 High Similarity NPC472548
0.8636 High Similarity NPC477905
0.8634 High Similarity NPC40138
0.8627 High Similarity NPC254558
0.8618 High Similarity NPC327031
0.8609 High Similarity NPC470157
0.8609 High Similarity NPC184817
0.8609 High Similarity NPC70403
0.8609 High Similarity NPC470159
0.8609 High Similarity NPC96903
0.8609 High Similarity NPC177940
0.8609 High Similarity NPC472571
0.8609 High Similarity NPC200471
0.8609 High Similarity NPC476973
0.8609 High Similarity NPC469349
0.8609 High Similarity NPC472568
0.8609 High Similarity NPC472575
0.8609 High Similarity NPC472556
0.8609 High Similarity NPC471104
0.8609 High Similarity NPC171525
0.8609 High Similarity NPC158663
0.8609 High Similarity NPC473088
0.8609 High Similarity NPC29704
0.8609 High Similarity NPC174982
0.8609 High Similarity NPC472572
0.8581 High Similarity NPC9905
0.8581 High Similarity NPC477098
0.8581 High Similarity NPC477100
0.8581 High Similarity NPC146310
0.8562 High Similarity NPC471493
0.8553 High Similarity NPC475552
0.8553 High Similarity NPC478263
0.8553 High Similarity NPC55744
0.8543 High Similarity NPC188865
0.8543 High Similarity NPC475759
0.8543 High Similarity NPC476974
0.8543 High Similarity NPC25768
0.8543 High Similarity NPC472570
0.8543 High Similarity NPC95265
0.8543 High Similarity NPC472573
0.8543 High Similarity NPC475122
0.8543 High Similarity NPC38696
0.8543 High Similarity NPC11685
0.8543 High Similarity NPC163719
0.8543 High Similarity NPC95810
0.8543 High Similarity NPC241951
0.8543 High Similarity NPC472569
0.8543 High Similarity NPC57628
0.8543 High Similarity NPC70716
0.8543 High Similarity NPC125106
0.8543 High Similarity NPC470152
0.8514 High Similarity NPC39549
0.8509 High Similarity NPC325732
0.8509 High Similarity NPC324769
0.8506 High Similarity NPC477101
0.8506 High Similarity NPC232583
0.8506 High Similarity NPC25484
0.8506 High Similarity NPC477097
0.8506 High Similarity NPC476173
0.8506 High Similarity NPC477099
0.85 High Similarity NPC478073
0.8497 Intermediate Similarity NPC205389
0.8497 Intermediate Similarity NPC473760
0.8491 Intermediate Similarity NPC476077
0.8487 Intermediate Similarity NPC478264
0.8487 Intermediate Similarity NPC301946
0.8487 Intermediate Similarity NPC277053
0.8481 Intermediate Similarity NPC159692
0.8477 Intermediate Similarity NPC163087
0.8467 Intermediate Similarity NPC242355
0.8462 Intermediate Similarity NPC469477
0.8462 Intermediate Similarity NPC133430
0.8446 Intermediate Similarity NPC52523
0.8446 Intermediate Similarity NPC472551
0.8446 Intermediate Similarity NPC472545
0.8446 Intermediate Similarity NPC217673
0.8442 Intermediate Similarity NPC270590
0.8442 Intermediate Similarity NPC473403
0.8442 Intermediate Similarity NPC266265
0.8442 Intermediate Similarity NPC301556
0.8442 Intermediate Similarity NPC471101
0.8442 Intermediate Similarity NPC92293

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC11410 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8013 Intermediate Similarity NPD7236 Approved
0.8 Intermediate Similarity NPD8368 Discontinued
0.7977 Intermediate Similarity NPD8434 Phase 2
0.7976 Intermediate Similarity NPD7799 Discontinued
0.7965 Intermediate Similarity NPD8407 Phase 2
0.7875 Intermediate Similarity NPD7239 Suspended
0.7816 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7784 Intermediate Similarity NPD8360 Approved
0.7784 Intermediate Similarity NPD8361 Approved
0.7684 Intermediate Similarity NPD8435 Approved
0.7616 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7527 Intermediate Similarity NPD8485 Approved
0.7472 Intermediate Similarity NPD8150 Discontinued
0.744 Intermediate Similarity NPD7057 Phase 3
0.744 Intermediate Similarity NPD7058 Phase 2
0.7405 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD2629 Approved
0.7308 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD4628 Phase 3
0.7193 Intermediate Similarity NPD7075 Discontinued
0.7178 Intermediate Similarity NPD6190 Approved
0.7143 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6599 Discontinued
0.7134 Intermediate Similarity NPD7961 Discontinued
0.7118 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD5402 Approved
0.7059 Intermediate Similarity NPD6801 Discontinued
0.7018 Intermediate Similarity NPD5760 Phase 2
0.7018 Intermediate Similarity NPD5761 Phase 2
0.7018 Intermediate Similarity NPD7819 Suspended
0.7006 Intermediate Similarity NPD7473 Discontinued
0.7 Intermediate Similarity NPD7741 Discontinued
0.7 Intermediate Similarity NPD7685 Pre-registration
0.699 Remote Similarity NPD8462 Phase 1
0.6971 Remote Similarity NPD8127 Discontinued
0.6944 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6941 Remote Similarity NPD4380 Phase 2
0.6935 Remote Similarity NPD8404 Phase 2
0.6931 Remote Similarity NPD7700 Phase 2
0.6931 Remote Similarity NPD7699 Phase 2
0.6923 Remote Similarity NPD8313 Approved
0.6923 Remote Similarity NPD8312 Approved
0.6919 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6913 Remote Similarity NPD4198 Discontinued
0.6909 Remote Similarity NPD8166 Discontinued
0.6906 Remote Similarity NPD6764 Approved
0.6906 Remote Similarity NPD6765 Approved
0.6891 Remote Similarity NPD8320 Phase 1
0.6891 Remote Similarity NPD8319 Approved
0.6886 Remote Similarity NPD6799 Approved
0.6879 Remote Similarity NPD3817 Phase 2
0.6864 Remote Similarity NPD5403 Approved
0.6862 Remote Similarity NPD6534 Approved
0.6862 Remote Similarity NPD6535 Approved
0.6846 Remote Similarity NPD690 Clinical (unspecified phase)
0.6845 Remote Similarity NPD2532 Approved
0.6845 Remote Similarity NPD2534 Approved
0.6845 Remote Similarity NPD2533 Approved
0.6839 Remote Similarity NPD7435 Discontinued
0.6839 Remote Similarity NPD3882 Suspended
0.6836 Remote Similarity NPD6232 Discontinued
0.6833 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6833 Remote Similarity NPD5844 Phase 1
0.6803 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6797 Remote Similarity NPD3412 Clinical (unspecified phase)
0.6792 Remote Similarity NPD7008 Discontinued
0.6784 Remote Similarity NPD3226 Approved
0.6778 Remote Similarity NPD3751 Discontinued
0.6778 Remote Similarity NPD3818 Discontinued
0.6776 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6766 Remote Similarity NPD7274 Clinical (unspecified phase)
0.6763 Remote Similarity NPD37 Approved
0.6761 Remote Similarity NPD5537 Clinical (unspecified phase)
0.676 Remote Similarity NPD6166 Phase 2
0.676 Remote Similarity NPD6168 Clinical (unspecified phase)
0.676 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6757 Remote Similarity NPD6785 Approved
0.6757 Remote Similarity NPD6784 Approved
0.675 Remote Similarity NPD3764 Approved
0.6746 Remote Similarity NPD5401 Approved
0.6743 Remote Similarity NPD4967 Phase 2
0.6743 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6743 Remote Similarity NPD4965 Approved
0.6743 Remote Similarity NPD4966 Approved
0.6728 Remote Similarity NPD230 Phase 1
0.6727 Remote Similarity NPD5762 Approved
0.6727 Remote Similarity NPD5763 Approved
0.6724 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6723 Remote Similarity NPD5494 Approved
0.6721 Remote Similarity NPD6559 Discontinued
0.6717 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6717 Remote Similarity NPD7874 Approved
0.6709 Remote Similarity NPD5740 Clinical (unspecified phase)
0.6709 Remote Similarity NPD6085 Phase 2
0.6707 Remote Similarity NPD2799 Discontinued
0.6706 Remote Similarity NPD6273 Approved
0.6705 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6686 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6686 Remote Similarity NPD7458 Discontinued
0.6685 Remote Similarity NPD7808 Phase 3
0.6684 Remote Similarity NPD6779 Approved
0.6684 Remote Similarity NPD6781 Approved
0.6684 Remote Similarity NPD6776 Approved
0.6684 Remote Similarity NPD6780 Approved
0.6684 Remote Similarity NPD6777 Approved
0.6684 Remote Similarity NPD6778 Approved
0.6684 Remote Similarity NPD6782 Approved
0.6667 Remote Similarity NPD2182 Approved
0.6667 Remote Similarity NPD1934 Approved
0.6667 Remote Similarity NPD7696 Phase 3
0.6667 Remote Similarity NPD7497 Discontinued
0.6667 Remote Similarity NPD2935 Discontinued
0.6667 Remote Similarity NPD7698 Approved
0.6667 Remote Similarity NPD6234 Discontinued
0.6667 Remote Similarity NPD7697 Approved
0.6667 Remote Similarity NPD6831 Clinical (unspecified phase)
0.6648 Remote Similarity NPD3787 Discontinued
0.6647 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6647 Remote Similarity NPD8389 Clinical (unspecified phase)
0.6645 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6633 Remote Similarity NPD7870 Phase 2
0.6633 Remote Similarity NPD7871 Phase 2
0.663 Remote Similarity NPD7251 Discontinued
0.6629 Remote Similarity NPD2801 Approved
0.6627 Remote Similarity NPD2346 Discontinued
0.6626 Remote Similarity NPD6355 Discontinued
0.6623 Remote Similarity NPD5951 Approved
0.6622 Remote Similarity NPD6371 Approved
0.6616 Remote Similarity NPD7701 Phase 2
0.6612 Remote Similarity NPD7074 Phase 3
0.6609 Remote Similarity NPD7411 Suspended
0.6607 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6607 Remote Similarity NPD2575 Approved
0.6607 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6606 Remote Similarity NPD651 Clinical (unspecified phase)
0.6606 Remote Similarity NPD7305 Phase 1
0.66 Remote Similarity NPD7801 Approved
0.6593 Remote Similarity NPD7228 Approved
0.659 Remote Similarity NPD6591 Clinical (unspecified phase)
0.6587 Remote Similarity NPD970 Clinical (unspecified phase)
0.6581 Remote Similarity NPD5125 Phase 3
0.6581 Remote Similarity NPD5126 Approved
0.6579 Remote Similarity NPD7115 Discovery
0.6577 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6576 Remote Similarity NPD6797 Phase 2
0.6557 Remote Similarity NPD7054 Approved
0.6554 Remote Similarity NPD7768 Phase 2
0.6552 Remote Similarity NPD6647 Phase 2
0.655 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6548 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6529 Remote Similarity NPD3300 Phase 2
0.6527 Remote Similarity NPD7702 Clinical (unspecified phase)
0.6522 Remote Similarity NPD7472 Approved
0.651 Remote Similarity NPD2067 Discontinued
0.6507 Remote Similarity NPD1237 Approved
0.6503 Remote Similarity NPD6663 Approved
0.6497 Remote Similarity NPD4807 Approved
0.6497 Remote Similarity NPD4806 Approved
0.6497 Remote Similarity NPD6287 Discontinued
0.6486 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6484 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6474 Remote Similarity NPD5306 Approved
0.6474 Remote Similarity NPD5305 Approved
0.6463 Remote Similarity NPD5048 Discontinued
0.646 Remote Similarity NPD5736 Approved
0.6453 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6453 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6452 Remote Similarity NPD6319 Approved
0.6452 Remote Similarity NPD9545 Approved
0.645 Remote Similarity NPD2800 Approved
0.6447 Remote Similarity NPD6823 Phase 2
0.6442 Remote Similarity NPD2313 Discontinued
0.6432 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6429 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6429 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6429 Remote Similarity NPD6004 Phase 3
0.6429 Remote Similarity NPD7266 Discontinued
0.6429 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6429 Remote Similarity NPD6002 Phase 3
0.6429 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6429 Remote Similarity NPD6005 Phase 3
0.6425 Remote Similarity NPD3749 Approved
0.6418 Remote Similarity NPD8151 Discontinued
0.6416 Remote Similarity NPD1512 Approved
0.6416 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6412 Remote Similarity NPD7003 Approved
0.6412 Remote Similarity NPD3750 Approved
0.6409 Remote Similarity NPD6959 Discontinued
0.6409 Remote Similarity NPD7199 Phase 2
0.6407 Remote Similarity NPD7033 Discontinued
0.6407 Remote Similarity NPD1510 Phase 2
0.64 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6398 Remote Similarity NPD5647 Approved
0.6395 Remote Similarity NPD164 Approved
0.6394 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6391 Remote Similarity NPD1549 Phase 2
0.6389 Remote Similarity NPD919 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data